There’s an increasing volume of computerised prescriptions each month where the prescriber has prescribed a generic Drug Tariff Part VIIIA product but also with the name of the branded product or the supplier/ manufacturer added in brackets.
In these situations, the drug costs charged to the prescriber’s budget and reimbursed to the community pharmacy or dispensing practice will be that of the list price of the branded medicine or the specified supplier.
In many cases this cost will be significantly higher than the Drug Tariff Part VIIIA listed price.
To help SICBLs monitor this scenario more closely and explore opportunities for review, we’ve developed this dashboard to highlight the details of practices and drugs where this is most common.
If you're registered, you can access the Premium Priced Generics dashboard via ePACT2.